XML 17 R6.htm IDEA: XBRL DOCUMENT v2.3.0.15
Consolidated Statements of Cash Flows (Unaudited) (USD $)
9 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Cash flows from operating activities:  
Net loss$ (6,867,293)$ (2,614,360)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:  
Depreciation, depletion, and amortization6,597,54442,927
Equity in loss of unconsolidated subsidiaries 316,908
Bad debt expense159,213 
Share-based compensation700,676507,520
Deferred income taxes(1,555,649) 
Accretion of discount on asset retirement obligations(50,078)3,125
Amortization of debt discount134,121 
Amortization of deferred financing fees297,36438,892
Accretion of Senior Series A redeemable preferred stock liability2,829,545 
Change in fair value of derivative liabilities(355,387) 
Loss on litigation settlement965,065 
(Gain) loss on sale of assets, net(16,878)403,848
Change in working capital:  
Accounts receivable(3,796,871)(196,925)
Inventories(111,487) 
Prepaid expenses and other(1,587,510)(151)
Accounts payable and accrued expenses3,138,829(92,753)
Other liabilities68,181138,896
Net cash provided by (used in) operating activities549,385(1,452,073)
Cash flows from investing activities:  
Investments in oil and gas properties (2,160)
Investments in unconsolidated subsidiaries (108,500)
Additions to property, plant, and equipment(4,997,362) 
Proceeds from sale of property, plant, and equipment1,298,679859,408
Proceeds from sale of unconsolidated subsidiaries 400,000
Net cash provided by (used in) investing activities(3,698,683)1,148,748
Cash flows from financing activities:  
Proceeds from the issuance of common stock and warrants12,500181,100
Proceeds from the issuance of Series A convertible preferred stock369,470 
Proceeds from the issuance of 9% convertible debentures936,000 
Borrowings under revolving credit facility63,120,440 
Payments under revolving credit facility(63,401,026) 
Borrowings under notes payable3,883,7731,509,791
Payments on notes payable(1,918,150)(629,895)
Net cash provided by financing activities3,003,0071,060,996
Net increase (decrease) in cash and cash equivalents(146,291)757,671
Cash and cash equivalents at beginning of year209,49818,136
Cash and cash equivalents at end of year$ 63,207$ 775,807